ctrlnum 54819
fullrecord <?xml version="1.0"?> <dc schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><relation>http://eprints.umm.ac.id/54819/</relation><title>STUDI PENGGUNAAN LAKTULOSA PADA PASIEN SIROSIS HATI DENGAN HEPATIK ENSEFALOPATI (Penelitian Dilakukan di Rumah Sakit Umum Daerah Sidoarjo)</title><creator>Alhamid, Salfa</creator><subject>RS Pharmacy and materia medica</subject><description>Background : Hepatic Encephalophaty is a neuropsychiatric syndrome occuring in patient with cirrhosis characterized by pugnacious, memory and conscious impairment to coma. Hepatic encephalophaty is caused by brain toxicity of impaired detoxification of ammonia due to liver dysfunction. Lactulose as single or combination use has benefit to prevent and improve hepatic encephalophaty. Lactulose reduce blood ammonia by decrease it&#x2019;s absorption and increase elimination through feces.&#xD; Objective : To identify the pattern of lactulose use in cirrhosis patients with hepatic encephalophaty in Regional Public Hospital of Sidoarjo.&#xD; Method : Observational descriptive and retrospective design in cirrhosis patients with hepatic encephalophaty period June 2016-june 2019.&#xD; Result &amp; Conclusion : The patern of lactulose is in single use for 6 patients (32%) and combination for 13 patients (68%). Single lactulose therapy that mostly used was (3x10g) orally by 5 patients (83%) and for combination was Lactulose (3x20g) orally + Comafusin&#xAE; hepar (12,5g BCAA) intravenous by 5 patient (39%).</description><date>2019-11-06</date><type>Thesis:Thesis</type><type>PeerReview:NonPeerReviewed</type><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/1/PENDAHULUAN.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/2/BAB%20I.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/3/BAB%20II.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/4/BAB%20III.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/5/BAB%20IV.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/6/BAB%20V.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/7/BAB%20VI.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/8/BAB%20VII.pdf</identifier><type>Book:Book</type><language>eng</language><identifier>http://eprints.umm.ac.id/54819/9/LAMPIRAN.pdf</identifier><identifier> Alhamid, Salfa (2019) STUDI PENGGUNAAN LAKTULOSA PADA PASIEN SIROSIS HATI DENGAN HEPATIK ENSEFALOPATI (Penelitian Dilakukan di Rumah Sakit Umum Daerah Sidoarjo). Bachelors Degree (S1) thesis, University of Muhammadiyah Malang. </identifier><recordID>54819</recordID></dc>
language eng
format Thesis:Thesis
Thesis
PeerReview:NonPeerReviewed
PeerReview
Book:Book
Book
author Alhamid, Salfa
title STUDI PENGGUNAAN LAKTULOSA PADA PASIEN SIROSIS HATI DENGAN HEPATIK ENSEFALOPATI (Penelitian Dilakukan di Rumah Sakit Umum Daerah Sidoarjo)
publishDate 2019
topic RS Pharmacy and materia medica
url http://eprints.umm.ac.id/54819/1/PENDAHULUAN.pdf
http://eprints.umm.ac.id/54819/2/BAB%20I.pdf
http://eprints.umm.ac.id/54819/3/BAB%20II.pdf
http://eprints.umm.ac.id/54819/4/BAB%20III.pdf
http://eprints.umm.ac.id/54819/5/BAB%20IV.pdf
http://eprints.umm.ac.id/54819/6/BAB%20V.pdf
http://eprints.umm.ac.id/54819/7/BAB%20VI.pdf
http://eprints.umm.ac.id/54819/8/BAB%20VII.pdf
http://eprints.umm.ac.id/54819/9/LAMPIRAN.pdf
http://eprints.umm.ac.id/54819/
contents Background : Hepatic Encephalophaty is a neuropsychiatric syndrome occuring in patient with cirrhosis characterized by pugnacious, memory and conscious impairment to coma. Hepatic encephalophaty is caused by brain toxicity of impaired detoxification of ammonia due to liver dysfunction. Lactulose as single or combination use has benefit to prevent and improve hepatic encephalophaty. Lactulose reduce blood ammonia by decrease it’s absorption and increase elimination through feces. Objective : To identify the pattern of lactulose use in cirrhosis patients with hepatic encephalophaty in Regional Public Hospital of Sidoarjo. Method : Observational descriptive and retrospective design in cirrhosis patients with hepatic encephalophaty period June 2016-june 2019. Result & Conclusion : The patern of lactulose is in single use for 6 patients (32%) and combination for 13 patients (68%). Single lactulose therapy that mostly used was (3x10g) orally by 5 patients (83%) and for combination was Lactulose (3x20g) orally + Comafusin® hepar (12,5g BCAA) intravenous by 5 patient (39%).
id IOS4109.54819
institution Universitas Muhammadiyah Malang
institution_id 136
institution_type library:university
library
library Perpustakaan Universitas Muhammadiyah Malang
library_id 546
collection UMM Institutional Repository
repository_id 4109
city MALANG
province JAWA TIMUR
repoId IOS4109
first_indexed 2019-11-23T23:29:48Z
last_indexed 2019-11-23T23:29:48Z
recordtype dc
_version_ 1686087605245968384
score 17.538404